Fulgent Genetics(FLGT) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Fulgent Reports First Quarter 2025 Financial Results EL MONTE, CA, May 2, 2025 — Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31, 2025. First Quarter 2025 Results: Note: 1) Core Revenue is revenue calculated in accordance with GAAP minus revenue from COVID-19 testing products and servic ...